| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bce2a0580075d1784b839fe7636774a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1e74cc08c81de21e3849eee8260c233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16ebbf2b5f669829588fc45dd1118668
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bff3152f8d72c4e669a7e57be005c79 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1068 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15 |
| filingDate |
2015-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04a0c1ea540802746aa9cae58140eab9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_714061873cad1e5ab6684952b636f03f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07c235eaa380d2f18492b1674836a1d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47fbc5c41a1579c56ab8e8a48b1c8877 |
| publicationDate |
2017-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017073734-A1 |
| titleOfInvention |
Diagnostic for Sepsis |
| abstract |
A method of diagnosing severe sepsis prior to definitive clinical diagnosis. A pattern of gene expression that correlates strongly with a future diagnosis of severe sepsis and organ failure was identified in patients who had their blood drawn at first clinical presentation. The methods comprise identifying a pattern of two or more polynucleotides, whereby the altered expression of these polynucleotides correlates with prospective and actual sepsis. Also methods of identifying agents for treating sepsis based on the characteristics of this gene expression pattern are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023165573-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020257358-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021222537-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114292813-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021026129-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11504071-B2 |
| priorityDate |
2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |